Swiss pharma giant Roche has announced new data from the Phase III METEOROID study demonstrating that Enspryng (satralizumab) ...
US pharma giant Merck & Co and Japan’s Eisai today announced results from the Phase III LITESPARK-012 trial evaluating combination regimens for the first-line treatment of patients with advanced clear ...
US biotech Moderna today announced that the European Commission (EC) has granted marketing authorization for mCOMBRIAX ...
The US Food and Drug Administration (FDA) accepted for Priority Review a supplemental Biologics License Application (sBLA) ...
Flagship Pioneering, a scientific innovation engine for transformative platforms and products, today announced the launch of ...
Axelpharm, the Russian manufacturer of anticancer generics, may suspend operations due to fines from the local antitrust ...
British pharma GSK (LSE: GSK) has won approval in China for Blenrep (belantamab mafodotin) with bortezomib and dexamethasone ...
US pharma major Eli Lilly (NYSE: LLY) has agreed to acquire US biotech Kelonia Therapeutics for up to $7 billion, adding an ...
US biotech Arcus Biosciences (NYSE: RCUS) has halted its Phase III STAR-121 study of domvanalimab in first-line ...
UK biotech Compass Pathways (Nasdaq: CMPS) saw its shares jump 42% after a White House executive order signaled a more ...
US biotech major Biogen and TJ Biopharma have entered into a definitive agreement under which Biogen has agreed to acquire TJ ...
The US Food and Drug Administration (FDA) has accepted Roche’s supplemental Biologics License Application (sBLA) for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results